个人中心 - 老虎社区

PigsMightFly

BUY THE FKING DIP

IP属地：未知

帖子 · 210帖子 · 210
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- PigsMightFlyPigsMightFly
  ·2021-06-14
  Like and comment thanks
  非常抱歉，此主贴已删除
  1,341 3
  6
  分享
  举报
- PigsMightFlyPigsMightFly
  ·2021-06-13
  Tiger coin
  838 评论
  点赞
  分享
  举报
- PigsMightFlyPigsMightFly
  ·2021-06-13
  Like and comment thanks
  非常抱歉，此主贴已删除
  1,276 1
  4
  分享
  举报
- PigsMightFlyPigsMightFly
  ·2021-06-12
  Like and comment thanks
  非常抱歉，此主贴已删除
  1,129 3
  2
  分享
  举报
- PigsMightFlyPigsMightFly
  ·2021-06-12
  Like and comment thanks
  2,031 评论
  点赞
  分享
  举报
- PigsMightFlyPigsMightFly
  ·2021-06-11
  Tiger coin
  990 评论
  2
  分享
  举报
- PigsMightFlyPigsMightFly
  ·2021-06-11
  Like and comment thanks
  Here’s why Art Cashin says the S&P 500′s move to a new record may be ‘slightly suspect’
  TheS&P 500hit an all-time high early Thursday, but longtime traderArt Cashin told CNBC he’s taking a
  Here’s why Art Cashin says the S&P 500′s move to a new record may be ‘slightly suspect’
  1,026 2
  4
  分享
  举报
- PigsMightFlyPigsMightFly
  ·2021-06-10
  Like and comment thanks
  非常抱歉，此主贴已删除
  971 4
  7
  分享
  举报
- PigsMightFlyPigsMightFly
  ·2021-06-09
  Like and comment thanks
  非常抱歉，此主贴已删除
  1,356 1
  1
  分享
  举报
- PigsMightFlyPigsMightFly
  ·2021-06-08
  Like and comment thanjs
  FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades
  (June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer
  FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades
  1,198 1
  2
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3574774155789598","uuid":"3574774155789598","gmtCreate":1611723388930,"gmtModify":1630743242322,"name":"PigsMightFly","pinyin":"pigsmightfly","introduction":"","introductionEn":"","signature":"BUY THE FKING DIP","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":18,"headSize":264,"tweetSize":210,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.16%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.00%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":182747330,"gmtCreate":1623624742220,"gmtModify":1631889781365,"author":{"id":"3574774155789598","authorId":"3574774155789598","name":"PigsMightFly","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574774155789598","authorIdStr":"3574774155789598"},"themes":[],"htmlText":"Like and comment thanks&nbsp;","listText":"Like and comment thanks&nbsp;","text":"Like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/182747330","repostId":"2142204074","repostType":4,"isVote":1,"tweetType":1,"viewCount":1341,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182061279,"gmtCreate":1623547475291,"gmtModify":1631889781357,"author":{"id":"3574774155789598","authorId":"3574774155789598","name":"PigsMightFly","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574774155789598","authorIdStr":"3574774155789598"},"themes":[],"htmlText":"Tiger coin","listText":"Tiger coin","text":"Tiger coin","images":[{"img":"https://static.tigerbbs.com/444950312d842dc9734a819f9411844e","width":"1125","height":"3405"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/182061279","isVote":1,"tweetType":1,"viewCount":838,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":182060746,"gmtCreate":1623547386985,"gmtModify":1631889781345,"author":{"id":"3574774155789598","authorId":"3574774155789598","name":"PigsMightFly","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574774155789598","authorIdStr":"3574774155789598"},"themes":[],"htmlText":"Like and comment thanks","listText":"Like and comment thanks","text":"Like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/182060746","repostId":"2142204074","repostType":4,"isVote":1,"tweetType":1,"viewCount":1276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186824637,"gmtCreate":1623486280829,"gmtModify":1631889781361,"author":{"id":"3574774155789598","authorId":"3574774155789598","name":"PigsMightFly","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574774155789598","authorIdStr":"3574774155789598"},"themes":[],"htmlText":"Like and comment thanks","listText":"Like and comment thanks","text":"Like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/186824637","repostId":"2142204074","repostType":4,"isVote":1,"tweetType":1,"viewCount":1129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186824119,"gmtCreate":1623486260831,"gmtModify":1631889781356,"author":{"id":"3574774155789598","authorId":"3574774155789598","name":"PigsMightFly","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574774155789598","authorIdStr":"3574774155789598"},"themes":[],"htmlText":"Like and comment thanks&nbsp;","listText":"Like and comment thanks&nbsp;","text":"Like and comment thanks","images":[{"img":"https://static.tigerbbs.com/fca39d05d31e3bf21cbe1375247ffa0f","width":"1125","height":"3317"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/186824119","isVote":1,"tweetType":1,"viewCount":2031,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":181033942,"gmtCreate":1623366515786,"gmtModify":1631889781360,"author":{"id":"3574774155789598","authorId":"3574774155789598","name":"PigsMightFly","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574774155789598","authorIdStr":"3574774155789598"},"themes":[],"htmlText":"Tiger coin","listText":"Tiger coin","text":"Tiger coin","images":[{"img":"https://static.tigerbbs.com/b49c94529fdec782b76751bf8e1cd58b","width":"1125","height":"3765"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/181033942","isVote":1,"tweetType":1,"viewCount":990,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":181030734,"gmtCreate":1623366468728,"gmtModify":1631889781358,"author":{"id":"3574774155789598","authorId":"3574774155789598","name":"PigsMightFly","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574774155789598","authorIdStr":"3574774155789598"},"themes":[],"htmlText":"Like and comment thanks","listText":"Like and comment thanks","text":"Like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/181030734","repostId":"1195294102","repostType":4,"repost":{"id":"1195294102","kind":"news","pubTimestamp":1623339220,"share":"https://www.laohu8.com/m/news/1195294102?lang=&edition=full","pubTime":"2021-06-10 23:33","market":"us","language":"en","title":"Here’s why Art Cashin says the S&P 500′s move to a new record may be ‘slightly suspect’","url":"https://stock-news.laohu8.com/highlight/detail?id=1195294102","media":"cnbc","summary":"TheS&P 500hit an all-time high early Thursday, but longtime traderArt Cashin told CNBC he’s taking a","content":"<div>\n<p>TheS&P 500hit an all-time high early Thursday, but longtime traderArt Cashin told CNBC he’s taking a wait-and-see approach before determining whether stocks are entering a steady upside move.\n“The ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/art-cashin-sp-500s-move-to-a-new-record-may-be-slightly-suspect.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s why Art Cashin says the S&P 500′s move to a new record may be ‘slightly suspect’</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s why Art Cashin says the S&P 500′s move to a new record may be ‘slightly suspect’\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 23:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/10/art-cashin-sp-500s-move-to-a-new-record-may-be-slightly-suspect.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TheS&P 500hit an all-time high early Thursday, but longtime traderArt Cashin told CNBC he’s taking a wait-and-see approach before determining whether stocks are entering a steady upside move.\n“The ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/art-cashin-sp-500s-move-to-a-new-record-may-be-slightly-suspect.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://www.cnbc.com/2021/06/10/art-cashin-sp-500s-move-to-a-new-record-may-be-slightly-suspect.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1195294102","content_text":"TheS&P 500hit an all-time high early Thursday, but longtime traderArt Cashin told CNBC he’s taking a wait-and-see approach before determining whether stocks are entering a steady upside move.\n“The market is a great tease here,” Cashin said on“Squawk on the Street.”“They go up, look like they’re breaking out, and then they hesitate. They pull back into that rectangle [trading range], so we’re going to give it a couple of days of testing and see what happens.”\nThe S&P 500 was up by about 0.3% on Thursday. The broad equity index has gained about 1% in the past month, compared with a roughly 4% gain for the tech-heavyNasdaq Composite.\nCashin, who serves as director of floor operations for UBS at the New York Stock Exchange, said he’s looking for an indication of strong buying pressure to help sustain the S&P 500′s move higher.\n“You’d like to believe when you punch through the upside of a market pattern, that inspires both breakout buying and, in some cases, short covering, so you should see a kind of burst after you move out,” Cashin said. “No burst so far, and without that then you’ve got to say the moves are slightly suspect.”\nThe Wall Street veteran also weighed in on the bond market following Thursday’shotter-than-expected read on May consumer prices, the latest data point showing inflationary pressures across the economy.\nThe yield on the benchmark 10-year Treasurywas steady Thursday,trading around 1.49%. Yields, which move inversely to prices, have trended lower in recent weeks afterhitting 1.7% about a month ago.\nCashin said a critical yield level to watch is 1.35%.\n“If any of these disinflationary, deflationary moves become evident, then I would have to back up. I think we might again start to move lower,” Cashin said, noting that there’s already been a relative cooling off in some commoditiessuch as lumber.\nIf the 10-year yield slides all the way back to 1.35% and “we move through it, then that will tell me that there is something going on here, that people are saying, ‘Inflation? No. Not at all,’” Cashin said. “We’re going from transitory to possibly deflationary. The question is wide open out there.”","news_type":1,"symbols_score_info":{".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1026,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189256432,"gmtCreate":1623278942726,"gmtModify":1631889781356,"author":{"id":"3574774155789598","authorId":"3574774155789598","name":"PigsMightFly","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574774155789598","authorIdStr":"3574774155789598"},"themes":[],"htmlText":"Like and comment thanks","listText":"Like and comment thanks","text":"Like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/189256432","repostId":"1188697627","repostType":4,"isVote":1,"tweetType":1,"viewCount":971,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180370757,"gmtCreate":1623192461079,"gmtModify":1631889781351,"author":{"id":"3574774155789598","authorId":"3574774155789598","name":"PigsMightFly","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574774155789598","authorIdStr":"3574774155789598"},"themes":[],"htmlText":"Like and comment thanks","listText":"Like and comment thanks","text":"Like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/180370757","repostId":"1193765977","repostType":4,"isVote":1,"tweetType":1,"viewCount":1356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114716449,"gmtCreate":1623105806481,"gmtModify":1631889781355,"author":{"id":"3574774155789598","authorId":"3574774155789598","name":"PigsMightFly","avatar":"https://static.tigerbbs.com/7b346eecabfd1938b479ec4791d40b71","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574774155789598","authorIdStr":"3574774155789598"},"themes":[],"htmlText":"Like and comment thanjs","listText":"Like and comment thanjs","text":"Like and comment thanjs","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/114716449","repostId":"1108033863","repostType":4,"repost":{"id":"1108033863","kind":"news","pubTimestamp":1623087360,"share":"https://www.laohu8.com/m/news/1108033863?lang=&edition=full","pubTime":"2021-06-08 01:36","market":"us","language":"en","title":"FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades","url":"https://stock-news.laohu8.com/highlight/detail?id=1108033863","media":"cnbc","summary":"(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer","content":"<div>\n<p>(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer's drug aducanumab, making it the first drug cleared by U.S. regulators to slow cognitive decline in...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 01:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer's drug aducanumab, making it the first drug cleared by U.S. regulators to slow cognitive decline in...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1108033863","content_text":"(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer's drug aducanumab, making it the first drug cleared by U.S. regulators to slow cognitive decline in people living with Alzheimer's and the first new medicine for the disease in nearly two decades.The FDA's decision was highly anticipated. The drug, which is marketed under the name Aduhelm, is also expected to generate billions of dollars in revenue for the company.\"We are well-aware of the attention surrounding this approval,\" Dr. Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, said in a press release. \"We understand that Aduhelm has garnered the attention of the press, the Alzheimer's patient community, our elected officials, and other interested stakeholders.\"\"With a treatment for a serious, life-threatening disease in the balance, it makes sense that so many people were following the outcome of this review,\" Cavazzoni added.Alzheimer’s disease is a progressive neurodegenerative disorder that slowly destroys memory and thinking skills. More than 6 million Americans are living with the disease, according toestimates by the Alzheimer’s Association.By 2050, that number is projected to rise to nearly 13 million, according to the group.There were previously no drugs cleared by the FDA that can slow the mental decline from Alzheimer’s, which is the sixth leading cause of death in the United States. The U.S. agency has approved Alzheimer’s drugs aimed at helping symptoms, not actually slowing the disease itself.Federal regulators have faced intense pressure from friends and family members of Alzheimer’s patients asking to fast-track aducanumab, but the road to regulatory approval has been a controversial one since it showed promise in 2016.In March of 2019, Biogen pulled work on the drug after an analysis from an independent group revealed it was unlikely to work. The company then shocked investors several months later by announcing it would seek regulatory approval for the drug after all.Shares of Biogen soared in Novemberafter it won backing from FDA staff, who said the company showed highly “persuasive” evidence aducanumab was effective and that it had “an acceptable safety profile that would support use in individuals with Alzheimer’s disease.”But two days later, a panel of outside experts that advises theU.S. agency unexpectedly declined to endorsethe experimental drug, citing unconvincing data. It also criticized agency staff for what it called an overly positive review.When Biogen sought approval for the drug in late 2019, its scientists said a new analysis of a larger data set showed that aducanumab “reduced clinical decline in patients with early Alzheimer’s disease.”Alzheimer’s experts and Wall Street analysts were immediately skeptical, with some wondering whether the clinical trial data was enough to prove that the drug works and whether approval could make it harder for other companies to enroll patients in their own drug trials.Some doctorshave said they won’t prescribethe drug if it does reach the market, because of the mixed data package supporting the company’s application.Supporters, including advocacy groups and family members of those living with the disease desperate for a new treatment, have acknowledged that the data isn’t perfect. However, they argue that it could help some patients with Alzheimer’s, a progressive and debilitating disease.Biogen’s drug targets a “sticky” compound in the brain known as beta-amyloid, which scientists expect plays a role in the devastating disease. The company has previously estimated about 1.5 million people with early Alzheimer’s in the U.S. could be candidates for the drug, according to Reuters.The FDA decision is expected to reverberate throughout the biopharma sector, RBC Capital Markets analyst Brian Abrahams said in a note to clients on June 1.The U.S. agency said Monday it determined there was “substantial evidence” the drug helps patients.“As a result of FDA’s approval of Aduhelm, patients with Alzheimer’s disease have an important and critical new treatment to help combat this disease,” it said.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":1198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}